Conversion of Recent-Onset Atrial Fibrillation by a Single Oral Dose of Pilsicainide (Pilsicainide Suppression Trial on Atrial Fibrillation)
- 15 September 1996
- journal article
- clinical trial
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 78 (6), 694-697
- https://doi.org/10.1016/s0002-9149(96)00401-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainideThe American Journal of Cardiology, 1994
- Flecainide single oral dose for management of paroxysmal supraventricular tachycardia in children and young adultsAmerican Heart Journal, 1992
- Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertensionThe American Journal of Cardiology, 1992
- Suppressive effect of SUN1165 on supraventricular tachycardiaAmerican Heart Journal, 1991
- Possible atrial proarrhythmic effects of class 1C antiarrhythmic drugsThe American Journal of Cardiology, 1990
- The hazards of using type 1C antiarrhythmic drugs for the treatment of paroxysmal atrial fibrillationThe American Journal of Cardiology, 1990
- Effect of SUN 1165, a New Potent Antiarrhythmic Agent, on the Kinetics of Rate-Dependent Block of Na Channels and Ventricular Conduction of ExtrasystolesJournal of Cardiovascular Pharmacology, 1988
- Use-dependent blocking action of newly developed lidocaine-analogs on maximum rate of rise of action potentials in guinea pig papillary muscle.Japanese Heart Journal, 1987
- Effective termination of reentrant supraventricular tachycardia by single dose oral combination therapy with pindolol and verapamilAmerican Heart Journal, 1986
- Electrophysiological Actions of N-(2,6-Dimethylphenyl)-8-Pyrrolizidine-Acetamide Hydrochoride Hemihydrate (SUN 1165), a New Antiarrhythmic AgentJournal of Cardiovascular Pharmacology, 1986